1. Schiele, F, Hochadel, M, Tubaro, M, et al. Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction. Eur Heart J. 2010;31:2614-24.
Google Scholar | Crossref | Medline | ISI2. Chan, AW, Kornder, J, Elliott, H, et al. Improved survival associated with pre-hospital triage strategy in a large regional ST-segment elevation myocardial infarction program. JACC Cardiovasc Interv. 2012;5:1239-46.
Google Scholar | Crossref | Medline3. Appleby, MA, Angeja, BG, Dauterman, K, Gibson, CM. Angiographic assessment of myocardial perfusion: TIMI myocardial perfusion (TMP) grading system. Heart. 2001;86:485-6.
Google Scholar | Crossref | Medline4. KunadianV, Harrigan, C, Zorkun, C, et al. Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years. J Thromb Thrombolysis. 2009;27:316-28.
Google Scholar | Crossref | Medline5. Gibson, CM, Cannon, CP, Daley, WL, et al. TIMI frame count. Circulation. 1996;93:879-88.
Google Scholar | Crossref | Medline | ISI6. Cannın, CP . Improtance of TIMI3 flow. Circulation. 2001;104:624-6.
Google Scholar | Crossref | Medline7. TIMI Study Group . The thrombolysis in myocardial infarction (TIMI) trial: phase I findings. NEJM. 1985;312:932-6.
Google Scholar | Crossref | Medline | ISI8. Gibson, CM, Cannon, CP, Daley, WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 2012;93:879-88.
Google Scholar | Crossref9. Appleby, MA, Michaels, AD, Chen, M, Michael, CG. Importance of the TIMI frame count: implications for future trials. Curr Contr Trials C. 2000;1:31-4.
Google Scholar | Medline10. Gibson, CM, Cannon, CP, Murphy, SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000;101:125-30.
Google Scholar | Crossref | Medline | ISI11. Manginas, A, Gatzov, P, Chasikidis, C, Voudris, V, Pavlides, G, Cokkinos, DV. Estimation of coronary flow reserve using the thrombolysis In myocardial infarction (TIMI) frame count method. Am J Cardiol. 1999;83:1562-4.
Google Scholar | Crossref | Medline12. Haager, PK, Christott, P, Heussen, N, Lepper, W, Hanrath, P, Hoffmann, R. Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by markers of myocardial reperfusion. J Am Coll Cardiol. 2003;41:532-8.
Google Scholar | Crossref | Medline13. Gibson, CM, Cannon, CP, Murphy, SA, Marble, SJ, Barron, HV, Braunwald, E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 2002;105:1909-13.
Google Scholar | Crossref | Medline14. Hamada, S, Nishiue, T, Nakamura, S, et al. TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute Myocardial Infarction. J Am Coll Cardiol 2001;38:666–71.
Google Scholar | Crossref | Medline15. Gibson, CM, Murphy, SA, Rizzo, MJ, et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation. 1999;99:1945-50.
Google Scholar | Crossref | Medline | ISI16. Killip, T, Kimball, JT. Treatment of myocardial infarction in a coronary care unit. Am J Cardiol. 1967;20:457-64.
Google Scholar | Crossref | Medline | ISI17. Lang, RM, Bierig, M, Devereux, RB, et al. Recommendations for chamber quantification☆. Eur J Echocardiogr. 2006;7:79-108.
Google Scholar | Crossref | Medline18. Thygesen, K, Alpert, JS, White, HD, et al. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525-38.
Google Scholar | Crossref | Medline | ISI19. Grines, CL, Westerhausen, DR, Grines, LL, et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction. J Am Coll Cardiol. 2002;39:1713-9.
Google Scholar | Crossref | Medline20. Eldar, M . Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. Ann Intern Med. 1992;117:31-6.
Google Scholar | Crossref | Medline21. Tajti, P, Burke, MN, Karmpaliotis, D, et al. Update in the percutaneous management of coronary chronic total occlusions. JACC Cardiovasc Interv. 2018;11:615-25.
Google Scholar | Crossref | Medline22. Sianos, G, Papafaklis, MI, Daemen, J, et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2007;50:573-83.
Google Scholar | Crossref | Medline | ISI23. SYNTAX working-group . SYNTAX score calculator; 2020. Available at: www.syntaxscore.com.
Google Scholar24. Tasar, O, Karabay, AK, Oduncu, V, Kirma, C. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coronary Artery Dis. 2019;30:270-6.
Google Scholar | Crossref | Medline25. Mahmoud, AH, Taha, NM, Baraka, K, Ashraf, M, Shehata, S. Clinical and procedural predictors of suboptimal myocardial reperfusion in primary percutaneous coronary intervention. IJC Heart and Vasculature. 2019;23:100357.
Google Scholar | Crossref | Medline26. Ghaffari, S, Tajlil, A, Aslanabadi, N, et al. Clinical and laboratory predictors of coronary slow flow in coronary angiography. Perfusion, 2017;32:13-9.
Google Scholar | SAGE Journals | ISI27. Angeja, BG, De Lemos, J, Murphy, SA, et al. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy. Am Heart J. 2002;144:649-56.
Google Scholar | Crossref | Medline28. Tarantini, G, Cacciavillani, L, Corbetti, F, et al. Duration of Ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty. JACC (J Am Coll Cardiol). 2005;46:1229-35.
Google Scholar | Crossref | Medline | ISI29. Bayramoğlu, A, Taşolar, H, Kaya, A, et al. Prediction of no-reflow and major adverse cardiovascular events with a new scoring system in STEMI patients. J Interv Cardiol. 2018;31:144-9.
Google Scholar | Crossref | Medline30. Liu, Q, Shepherd, BE, Li, C, Harrell, FE. Modeling continuous response variables using ordinal regression. Stat Med. 2017;36:4316-35.
Google Scholar | Crossref | Medline31. Lee, KL, Woodlief, LH, Topol, EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Circulation. 1995;91:1659-68.
Google Scholar | Crossref | Medline | ISI32. Morrow, DA, Antman, EM, Charlesworth, A, et al. TIMI Risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. Circulation. 2000;102:2031-2037.
Google Scholar | Crossref | Medline | ISI33. Kondo, M, Nakano, A, Saito, D, Shimono, Y. Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction. J Am Coll Cardiol. 1998;32:898-903.
Google Scholar | Crossref | Medline34. Kloner, RA, Ganote, CE, Jennings, RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496-1508.
Google Scholar | Crossref | Medline | ISI35. Bonnefont-Rousselot, D, Beaudeux, J-L, Thérond, P, Peynet, J, Legrand, A, Delattre, J. Diabetes mellitus, oxidative stress and advanced glycation end products. Ann Pharm Fr. 2004;62:147-157.
Google Scholar | Crossref | Medline36. Goldin, A, Beckman, JA, Schmidt, AM, Creager, MA. Advanced glycation end products. Circulation. 2006;114:597-605.
Google Scholar | Crossref | Medline | ISI37. Bibbins-Domingo, K, Bibbins-Domingo, K, Grossman, DC, et al. Statin use for the primary prevention of cardiovascular disease in adults. J Am Med Assoc. 2016;316:1997-2007.
Google Scholar | Crossref | Medline38. Satoh, M, Takahashi, Y, Tabuchi, T, et al. Cellular and molecular mechanisms of statins: an update on pleiotropic effects. Clinical Science. 2015;129:93-105.
Google Scholar | Crossref39. Ibanez, B, James, S, Agewall, S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017;39:119-177.
Google Scholar | Crossref40. Oduncu, V, Erkol, A, Kurt, M, et al. The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention. Nt J Cardiol. 2013;167:458-463.
Google Scholar41. Ortego, M, Bustos, C, Hernández-Presa, MA, et al. Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis. 1999;147:253-261.
Google Scholar | Crossref | Medline | ISI